The best time to take avatrombopag (Avatrombopag, Sucoxin)

Avatrombopag/Avatrombopag is a medicine used to treat certain types of thrombocytopenia, especially when surgery or other medical intervention is needed. In order to ensure the therapeutic effect, the best time and method of taking it are particularly important. Based on clinical studies and usage guidelines, patients should start taking avatropopag at least 10 days before planned surgery. Specifically, the dose of the drug is usually 2 to 3 tablets per day, depending on the platelet count at the start of treatment. A continuous 5-day course of treatment is essential to increase platelet counts.

On the day of surgery, a blood test is necessary to ensure that the platelet count is at a safe level and does not occur unexpectedly. Patients are advised to undergo surgery within 5 to 8 days after the last dose of avatropopag to avoid the risk of insufficient platelet counts. It is worth noting that if the patient misses a dose, he should avoid taking two doses at once and should continue taking them at the normal time the next day to ensure that the treatment course is complete and uninterrupted.

Regarding the pharmacokinetic properties of the drug, under fasting and fed conditions, after a single dose of avatrombopag, its average peak concentration usually occurs 5 to 8 hours after administration, while the half-life of the drug is 16 to 18 hours. This means that the drug is metabolized and cleared from the body at a more stable rate, helping to maintain required platelet levels. In addition, taking it with food does not have a significant impact on the rate or degree of absorption of avatrombopag, but the variability of pharmacokinetics is reduced when administered in the fasting state. Therefore, when taking the drug, it is recommended that patients choose the appropriate dosing method according to the recommendations of their doctor.

Reference materials:https://www.ema.europa.eu/en/medicines/human/EPAR/doptelet